An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5469-5474

  Ritchie, Jennifer M ^a   Greenwich, Jennifer L ^a   Davis, Brigid M ^a   Bronson, Roderick T ^b   Gebhart, Dana ^c   Williams, Steven R ^c   Martin, David ^c   Scholl, Dean ^c   Waldor, Matthew K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c AvidBiotics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PYOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SHEDDING; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; ENTERITIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; BACTERIAL LOAD; DIARRHEA; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FECES; GENETIC ENGINEERING; HUMANS; PYOCINS; RABBITS; TREATMENT OUTCOME;

EID: 81555206712     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05031-11     Document Type: Article

References (27)

1. Brando, R. J., et al. 2008. Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producing Escherichia coli strains. Clin. Exp. Immunol. 153:297-306. (Pubitemid 351989167)
2. Haas, H., T. Sacks, and N. Saltz. 1974. Protective effect of pyocin against lethal Pseudomonas aeruginosa infections in mice. J. Infect. Dis. 129:470-472.
3. Ho, T. D., B. M. Davis, J. M. Ritchie, and M. K. Waldor. 2008. Type 2 secretion promotes enterohemorrhagic Escherichia coli adherence and intestinal colonization. Infect. Immun. 76:1858-1865. (Pubitemid 351656119)
4. Mead, P. S., and P. M. Griffin. 1998. Escherichia coli O157:H7. Lancet 352:1207-1212. (Pubitemid 28458545)
5. Merrikin, D. J., and C. S. Terry. 1972. Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice. Appl. Microbiol. 23:164-165.
6. Michel-Briand, Y., and C. Baysse. 2002. The pyocins of Pseudomonas aeruginosa. Biochimie 84:499-510. (Pubitemid 35350881)
7. Nakayama, K., et al. 2000. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol. Microbiol. 38:213-231.
8. Nelson, J. M., P. M. Griffin, T. F. Jones, K. E. Smith, and E. Scallan. 2011. Antimicrobial and antimotility agent use in persons with Shiga toxin-producing Escherichia coli O157 infection in FoodNet sites. Clin. Infect. Dis. 52:1130-1132.
9. O'Brien, A. D., et al. 1992. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180:65-94.
10. Pennington, H. 2010. Escherichia coli O157. Lancet 376:1428-1435.
11. Richardson, S. E., et al. 1992. Experimental verocytotoxemia in rabbits. Infect. Immun. 60:4154-4167.
12. Riley, L. W., et al. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N. Engl. J. Med. 308:681-685. (Pubitemid 13157770)
13. 2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect. Immun. 71: 7129-7139.
14. Sauter, K. A., et al. 2008. Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. Infect. Immun. 76:4469-4478.
15. Schlech, W. F., III, D. P. Chase, and A. Badley. 1993. A model of food-borne Listeria monocytogenes infection in the Sprague-Dawley rat using gastric inoculation: development and effect of gastric acidity on infective dose. Int. J. Food Microbiol. 18:15-24. (Pubitemid 23060976)
16. Scholl, D., et al. 2009. An engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7. Antimicrob. Agents Chemother. 53:3074-3080.
17. Scholl, D., and D. W. Martin, Jr. 2008. Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model. Antimicrob. Agents Chemother. 52:1647-1652. (Pubitemid 351614656)
18. Shinomiya, T., M. Osumi, and M. Kageyama. 1975. Defective pyocin particles produced by some mutant strains of Pseudomonas aeruginosa. J. Bacteriol. 124:1508-1521.
19. Siegler, R. L., et al. 2003. Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr. Nephrol. 18:92-96. (Pubitemid 41490292)
20. Sjogren, R., et al. 1994. Role of Shiga-like toxin I in bacterial enteritis: comparison between isogenic Escherichia coli strains induced in rabbits. Gastroenterology 106:306-317.
21. Stearns-Kurosawa, D. J., V. Collins, S. Freeman, V. L. Tesh, and S. Kurosawa. 2010. Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli. Infect. Immun. 78:2497-2504.
22. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga-toxin- producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086. (Pubitemid 40386785)
23. Uratani, Y., and T. Hoshino. 1984. Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential. J. Bacteriol. 157:632-636. (Pubitemid 14190954)
24. Varshosaz, J., et al. 2011. Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: an in vitro/in vivo evaluation in induced colitis in rat. J. Microencapsul. 28:62-73.
25. Williams, S. R., D. Gebhart, D. W. Martin, and D. Scholl. 2008. Retargeting R-type pyocins to generate novel bactericidal protein complexes. Appl. Environ. Microbiol. 74:3868-3876. (Pubitemid 351874919)
26. Wong, C. S., S. Jelacic, R. L. Habeeb, S. L. Watkins, and P. I. Tarr. 2000. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N. Engl. J. Med. 342:1930-1936. (Pubitemid 30419087)
27. Zhang, X., et al. 2000. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181:664-670. (Pubitemid 30131837)